Welcome to our website. It's always a work in progress and your feedback is welcome
     

 

 

Government e-petition to
Review Levothyroxine Generics

Closing Date: 13/03/2013

Following reports from prescribers and patients, the MHRA suspended the licence for Teva Levothyroxine 100 microgram tablets in February 2012 (see links below for more info).

In the aftermath of this, Malcolm Cooper, who's wife has hypothyroidism, set up a Government Epetition as follows:

Review Levothyroxine Generics

Responsible department: Department of Health

Levothroxine is an essential drug to maintain the health of persons suffering from hypothyroidism. Recently the medicines regulator had to take action to remove the licence for Teva Levothyroxine 100mcg tablets since their dissolution rate was too low. A low dissolution rate means that the full dose of the drug is not absorbed by the body and as a result sufferers may die due to insufficient medication.

There is clear evidence in the public domain that other Generic brands of Levothyroxine suffer from the identical problem.

The Petitioners request that the Department of Health undertakes a full review of the bio-equivalence of all brands of Levothyroxine in all strengths and ensures that only those that pass fully retain their licence.

If you agree with this, then please sign the e-petition by following the link below.

http://epetitions.direct.gov.uk/petitions/31248 (Closing Date: 13/03/2013)

 

For more information about the problems with Teva levothyroxine 100mcg tablets,
see the MHRA press release for this, which can be downloaded here:
http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con143689.pdf

and the accompanying MHRA Teva Levothyroxine Questions and Answers document here:
http://www.mhra.gov.uk/home/groups/comms-po/documents/news/con143690.pdf